Relationship between allergic contact dermatitis and electrophilicity. by Rosenkranz, H S et al.
Articles
Relationship between Allergic Contact Dermatitis and Electrophilicity
Herbert S. Rosenkranz,1 Gilles Klopman,2 Ying Ping Zhang,1 Cynthia Graham,1 andMerylH. Karol1
1Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15238 USA; 2Department of
Chemistry, Case Western Reserve University, Cleveland, OH 44106 USA
To evaluate the role ofelectrophilicity in the induction ofallergic contact dermatitis (ACD) in
humans, we compared the strcture-activity relationship (SAR) model ofACD with those of
electrophilic and noneectrophilic subsets ofchemicals in theACD database. For these analses,
electrophilicity was defined as the potential of a chemical to induce mutations in Salmonellz It
was found that eleophilicity an d for appromately 30-40% ofACD-inducing ability,
and the remainder was associated with nonectrophiic structures. The identification of these
moieties opens the possibility for studying their role in ACD. Key work allergic contact der-
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One ofthe mechanistic paradigms associat-
ed with the disorder allergic cutaneous der-
matitis (ACD) is that the agent (i.e., elec-
trophile or proelectrophile) responsible for
eliciting this response attacks a nucleophilic
cellular target (1). Others suggest that it is
the overall reactivity that determines the
response (2). Electrophilicity is also associ-
ated with mutagenicity and carcinogenicity
(3,4). Mutagenic (genotoxic) carcinogens
are considered to pose a greater risk to
humans than nongenotoxic ones (5). The
relationship between ACD and other health
risks has recently been addressed by Albert
(6), who suggested a relationship between
ACD and nongenotoxic carcinogens. The
present study was undertaken to evaluate
this hypothesis, to determine the extent to
which electrophilicity contributes to ACD,
and possibly to identify other, nonelec-
trophilic, mechanisms that also contribute
to ACD. Our approach was based on our
earlier observation that the structural basis
ofACD in humans could be modeled suc-
cessfully by an expert structure-activity
relationship (SAR) system (7-9) yielding a
predictivity of84%. The approach we have
taken here was to derive SAR submodels for
electrophilic and nonelectrophilic chemicals
in the ACD database and to compare fea-
tures ofthe two submodels.
Methods
CASE/MULTICASE. The algorithms
employed within CASE and MULTICASE
(Multicase, Inc., Beachwood, OH) have
been described previously (10-12). Briefly,
a set of chemicals and their respective
experimentally determined biological activi-
ties (quantitative or qualitative) were input
into a database. Both programs provide a
means to identify descriptors consisting of
molecular fragments, ranging from 2 to 10
heavy atoms along with their associated
hydrogens, which account for the biologi-
cal activity ofthe compounds under study.
The molecular fragments are generated as a
result of breaking down each individual
chemical structure within the database into
its constituent parts. Each fragment is
"labeled" with respect to its origin within
active or inactive structures. Fragments of
relevance are those that exhibit a statistical-
ly significant nonrandom distribution
among the active and inactive classes of
compounds. In addition to using molecu-.
lar fragments, MULTICASE identifies rel-
evant two-dimensional distances between
atoms within a chemical structure.
At this point within the analysis, CASE
uses the statistically significant fragments
in order to classify compounds as active or
inactive. Predictions for submitted com-
pounds are expressed as percent probabili-
ties (0-100%) of being active or inactive.
In addition, CASE utilizes the molecular
fragments of the total database to derive a
"global" quantitative structure-activity
relationship (QSAR), which is used to pre-
dict the potency or extent of activity.
These two predictions are derived indepen-
dently ofone another.
MULTICASE, on the other hand, uses
the set ofstatistically significant descriptors
(fragment and/or distance) to find a
descriptor (biophore) that has the highest
probability of being responsible for the
observed biological activity. Compounds
within the database that contain the pri-
mary biophore are removed from the
analysis, and subsequent biophores that
explain the activity of the remaining com-
pounds are selected. This iterative process
ofselection is continued until either all of
the active compounds are accounted for or
no statistically significant descriptors
remain. The presence of biophores deter-
mines the likelihood of a compound to
exhibit activity. Predictions made on com-
pounds submitted for SAR analysis consist
of the identification of the biophore(s)
responsible for activity and the percent
probability ofthe compound being biologi-
cally active due to such occurrences. A com-
pound is presumed to be inactive if it con-
tains no biophores.
In MULTICASE, attempts are also
made to derive a "local" QSAR within each
group ofcompounds containing a particular
biophore in order to identify molecular fea-
tures that control the degree of activity.
These features, termed modulators, are
selected from the pool of molecular frag-
ments, distance descriptors, calculated elec-
tronic indices (molecular orbital energies,
charge densities), and calculated transport
parameters (octanol/water partition coeffi-
cient, water solubility). These local QSARs
are used to predict the potency ofchemicals
containingthespecific biophore.
The similarity between structural deter-
minants (i.e., biophores) associated with
specific SAR models is taken to be a mea-
sure of mechanistic similarity (13-15). For
this purpose, the biophores identified by
the CASE program were used. The bio-
phores selected were either identical (e.g.,
CH2-CH2- vs. CH2-CH2-) or embedded
(e.g., CH2-CH2- vs. CH2-CH2-CH2-). The
structural overlap was defined as number of
overlapping fragments/total number of sig-
nificant fragments.
The database of mutagenicity in
Salmonella was developed under the aegis of
the National Toxicology Program (NTP)
(16-21). An SAR model based upon subsets
ofthat database has been described (22).
Database. The database used for SAR
modeling was described previously (7,8).
With respect to the present analyses in the
model of ACD in humans, an "active"
chemical elicits a response in human patch
testing or has a sensitization rate of at least
16% in human maximization tests, when
given at a dose greater than 10%. A chemical
with "marginal" activity has a sensitization
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rate of 4-15% under the same conditions. Results and Discussion
An "inactive" chemical is one that has a sen- To classify the chemicals in the ACD data-
sitization rate of <4% in human maximiza- base into electrophiles/proelectrophiles and
tion testing. nonelectrophiles, we chose their potential
Table 1. Origin and composition ofthe three structure-activity relationship models
Characterization ACD (n) ACD-NE (n) ACD-EL(n)
Total database 767 652 179
ACD+ 355 266 88
ACDM 29 26 3
ACD- 383 366 88
Potential nonelectrophiles 652 652 52
Potential nonelectrophiles ACD+ 266 266 0
Potential nonelectrophiles ACD- 366 366 52
Potential electrophiles 114 0 127
Potential electrophiles ACD- 88 0 36
Potential electrophiles ACD+ 23 0 88
Abbreviations: ACD, allergic contact dermatitis; NE, nonelectrophiles; EL, elecrophiles.
ACD+, ACDM, and ACD- refer to chemicals shown experimentally to induce, marginally induce, and not induce allergic
contact dermatitis, respectively. Potential electrophiles and potential nonelectrophiles refer to chemicals predicted to be
mutagens and nonmutagens, respectively.
to induce mutations in Salmonella as a sur-
rogate for electrophilicity. This is based
upon the recognition 1) that mutagenicity
in Salmonella derives from an electrophilic
attack and 2) that the Salmonella muta-
genicity protocol includes testing in the
presence of an exogenous metabolic activa-
tion mixture, thereby making it possible to
identify proelectrophiles. Accordingly, we
used an SAR model of the induction of
mutations in Salmonella to classify chemi-
cals with known ACD-inducing activity as
potential electrophiles and nonelec-
trophiles. The predictivity ofthe model for
Salmonella mutagenicity assay is 81%;
however, because its sensitivity and speci-
ficity are approximately the same, the
chance of false positive and false negative
predictions is equal.
Table 2. Major CASE biophores associated with the parent allergic contactdermatitis structure-activity relationship model
Fragment Fragments
1 2 3 4 5 6 7 8 9 10 Sub (n) Inactives Marginals Actives p-Value No.
N -CH2- 50 1 0 49 0.000 1
N -CH3 26 1 0 25 0.000 2
N =C- 35 2 0 33 0.000 3
NH -C- 5 0 0 5 0.031 4
NH -CH- 10 0 0 10 0.001 5
NH -CH2- 26 1 1 24 0.000 6
NH -CH3 5 0 0 5 0.031 7
NH2 -CH2- 7 0 0 7 0.008 8
NH2 -NH- 5 0 0 5 0.031 9
Epoxide -CH2- 5 0 0 5 0.031 10
OH -C= 89 10 0 79 0.000 11
F -C- 6 0 0 6 0.016 12
S -C- 5 0 0 5 0.031 13
S -C= 14 0 0 14 0.000 14
SH -CH2- 19 0 1 18 0.000 15
Cl -CH2- 8 0 0 8 0.004 16
CS -N- 5 0 0 5 0.031 17
CS -S- . 5 0 0 5 0.031 18
CHa -CO -CH= 15 0 0 15 0.000 19
N -c =CH 19 0 0 19 0.000 20
NH -C =CH- 19 0 1 18 0.000 21
CO -C -C- 10 1 0 9 0.006 22
CH =C- CH= <2-NO2>b 5 0 0 5 0.031 23
CH2 -CH -CH2- <2-Epoxide> 5 0 0 5 0.031 24
CH2 =C -CH- <2-CO> 10 0 5 5 0.031 25
C =CH -CH =C- 141 36 3 102 0.000 26
CH =N -CH =CH- 8 0 0 8 0.004 27
NH2 -C =CH -C= 5 0 0 5 0.031 28
NH2 -C =CH -CH= 27 4 0 23 0.000 29
O -CO -C =CH2- 21 1 5 15 0.000 30
Cl -C =CH -C= 13 0 0 13 0.000 31
CH =C -CH =C- <2-0> 5 0 0 5 0.031 32
CH =C -C =C -C= 5 0 0 5 0.031 33
CH =C -C =C -CH= 25 1 0 24 0.000 34
CH =CH -CH =CH -Cc= 36 10 0 26 0.004 35
CH3 -C =CH -C =CH - 11 1 0 10 0.003 36
OH -CH2 -C =CH -CH= 5 0 0 5 0.031 37
CH =CH -CH =C -CH = <4-CO> 18 4 0 14 0.010 38
CH2 -CH2 -CH2 -C -CH2- <4-CH3> 5 0 0 5 0.031 39
CH2 -CH2 -CH2 -CH2 -CH2 -C= 15 0 0 15 0.000 40
< > indicates a substitutent. In biophore 36, the second and fourth carbon from the left are shown unsubstituted; this means they must be substituted by an atom other than hydrogen.
On the other hand, in biophore 38, the unsubstituted fourth carbon from the left can only be substituted by a CO moiety, whereas the second carbon from the left in biophore 38 is shown
with a hydrogen attached. No other atom can be atthat location.
'This moiety is attached by a double bond to an outside substituent.
bA nitro substituent is on the second carbon atom from the left.
cThis carbon atom is common to two rings.
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Overall, it should be noted that while
28.0% of the 384 ACD-inducing agents
were predicted to be mutagens, only 6% of
the 383 noninducing chemicals were pre-
dicted to be mutagens. This suggests that
electrophilicity is associated with ACD
(p.O.OOOl; X2 test), but that it is only one
of a number of factors because it cannot
explain the basis of the allergenicity ofthe
remaining 72% ofACD-inducing agents.
The ACD data available consisted of
917 chemicals tested in humans; however,
only 767 of these were used to construct
the SAR model. Recent studies have shown
that a ratio of active to inactive molecules
in the learning set ofunity was optimal for
developing SAR models (15). Because inac-
tive chemicals exceeded active ones, we
randomly deleted some of them (using a
computerized random number generator).
Our final model consisted of355 chemicals
that were active in the human patch test or
in the human maximization test, 29 mar-
ginally active and 383 inactive chemicals
(8). As a result, we had a surplus ofACD
noninducing chemicals that were not used
to construct the ACD SAR model. A total
of 652 of the 767 chemicals in the ACD
database (85.0%) were predicted to be
Salmonellanonmutagens (nonelectrophiles).
Of these, 266 (40.8%) were inducers of
ACD, 26 were marginal inducers, and 366
(56.1%) were noninducers ofACD (data-
base: ACD-NE) (Table 1).
One hundred fourteen ofthe chemicals
in the ACD database (14.9%) were pre-
dicted to be Salmonella mutagens (elec-
trophiles). Ofthese, 88 (77.2%) wereACD
inducers, 3 were marginal inducers, and 23
(20.2%) were noninducers. To increase the
number of potential electrophilic ACD
noninducers in the SAR model, we
screened the "excess" ACD noninducers (n
=150) that had not been used to construct
the original ACD SAR model. An addi-
tional 13 potential electrophilic non-ACD
inducers were thus identified. To bring the
ratio of ACD-active to ACD-inactive to
Table 3. Major CASE biophores associated withthe allergic contact dermatitis electrophilic (ACD-EL) structure-activity relationship submodel
Fragment Fragments
1 2 3 4 5 6 7 8 9 10 Sub (n) Inactives Marginals Actives p-Value No.
N -C= 10 0 0 10 0.001 1
N -CH2- 13 1 0 12 0.001 2
N -CH3- 7 0 0 7 0.008 3
NH =C- 12 1 0 11 0.002 4
NH -C= 5 1 0 14 0.000 5
NH -CH2- 10 0 0 10 0.001 6
NH2 -C= 20 1 0 19 0.000 7
Epoxide -CH2- 5 0 0 5 0.031 8
S -C= 9 0 0 9 0.002 9
Cl -CH2- 7 0 0 7 0.008 10
CO -N- 5 0 0 5 0.031 11
CH =C -C= <2-OH>8 7 1 0 6 0.035 12
CH =C -CH= <2-NO2> 5 0 0 5 0.031 13
CH2 -CH -CH2- <2-Epoxide> 5 0 0 5 0.031 14
C =CH -C =C- 17 1 0 16 0.000 15
C =CH -CH =C- 37 6 0 31 0.000 16
CH =C -CH =C- 15 1 0 14 0.000 17
NO2 -C =CH -CH= 11 0 0 11 0.000 18
< > indicates a substituent
'A hydroxyl group is on the second carbon from the left
Table 4. Major CASE biophores associatedwith allergic contactdermatitis nonelectrophilic (ACD-NE) structure-activitysubmodel
Fragment Fragments
1 2 3 4 5 6 7 8 9 10 Sub (n) Inactives Marginals Actives p-Value No.
N -CH2- 37 0 0 37 0.000 1
N -CH3 19 1 0 18 0.000 2
N =C- 23 1 0 22 0.000 3
NH -C= 14 0 1 13 0.000 4
NH -CH- 6 0 0 6 0.016 5
NH -CH2- 16 1 1 14 0.000 6
NH2 -CH2- 5 0 0 5 0.031 7
OH -C= 81 10 0 71 0.000 8
S -C= 5 0 0 5 0.031 9
SH -CH2- 16 0 1 15 0.000 10
CO -NH- 17 0 1 16 0.000 11
N -C =CH- 10 0 0 10 0.001 12
Cl -C =CH- 24 1 0 23 0.000 13
CO -C -C- 6 0 0 6 0.016 14
CO -CH =CH2- 9 0 0 9 0.002 15
CH =C -CH = <2-NH2>8 6 0 0 6 0.016 16
CH =C -C =C- 21 0 0 21 0.000 17
CH =N -CH =CH- 8 0 0 8 0.004 18
O -CO -C =CH2- 19 1 5 13 0.000 19
OH -CH2 -C =CH -CH= 5 0 0 5 0.031 20
CH =CH -CH =C -C= <4-CH2> 8 0 0 8 0.004 21
< > indicates a substituent
'An amino group is on the second carbon from the left.
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Table 5. Summary of structural overlaps among
allergic contact dermatitis(ACD) models
SAR model Compared to Overlap
ACD (total) ACD 100%
ACD-EL 42%
ACD-NE 73%
ACD-NE ACD-NE 100%
(nonelectrophiles) ACD 95%
ACD-EL 45%
ACD-EL ACD-EL 100%
(electrophiles) ACD 100%
ACD-NE 63%
SAR, structure-activity relationship. Structural overlaps
were determined as described in "Methods"; they are
based upon the biophores ofTables 2, 3, and 4 as well as
expanded fragments derived from them.
unity, we included an additional 52 ACD
noninducers randomly selected from the
data set (Table 1). The inclusion ofpoten-
tially nonelectrophilic non-ACD inducers
should not affect the SAR analyses to be
performed, as we were interested only in
activating moieties (biophores). Thus, this
database (ACD-EL) consisted of 88 ACD
inducers, 3 marginal inducers, and 88 non-
inducers (Table 1). Using CASE/MULTI-
CASE we developed SAR models for the
ACD, ACD-EL, and ACD-NE databases.
The major biophores associated with the
"parent" ACD SAR model (Table 2) are, as
expected, also present in the putative elec-
trophilic (ACD-EL, Table 3) and nonelec-
trophiic (ACD-NE, Table 4) SAR submod-
els. Indeed, this is further evidenced by the
extent of the structural overlap (i.e., com-
monality offagmnents) between ACD on one
hand and ACD-EL (42%) and ACD-NE
(73%) on the other (e.g., Fragment 5 in
Table 3 is identical to Fragment 4 inTable 4,
etc.) (Table 5). This clearly suggests that the
induction ofACD is not solely due to elec-
trophiicity. However, as expected, theACD-
EL SARmodel dearly contains typically elec-
trophiic biophores (Table 3, biophores 7, 8,
18; e.g., arylamines, epoxides, and ortho-sub-
stituted nitroarenes) that are absent from the
ACD-NE SAR model (Table 4). Further
indication that ACD-EL and ACD-NE
models reflect common, nonelectrophilic
mechanisms ofACD induction is the sub-
stantial structural overlap between ACD-NE
andACD-EL, 45-63% (Table 5). Moreover,
the ACD-NE model is highly predictive of
the chemicals inACD-EL andvice versa (i.e.,
85 and 78% respectively, Table6).
Thefindings described in this paper indi-
cate that while electrophilicity is associated
with the potential for inducing ACD, it is
Table 6. Cross-predictivities ofthe two structure-activity relationship (SAR) submodels
SAR model Chemicals being predicteda Concordance p-Value*
ACD-NE (n=652) ACD-EL(electrophiles) (n= 179) 85.0% <0.00001
ACD-EL (n= 179) ACD-NE (nonelectrophiles) (n= 652) 78.1% <0.00001
ACD, allergic contact dermatitis.
,'The ACD-NE SAR model was usedto predictthe ACD-inducing ability ofthe chemicals used to derive the ACD-EL model and vice versa.
*Statistical significance ofthe concordance between experimental and predicted results.
probably only one of the mechanisms
involved. Clearly, the nonelectrophilic bio-
phores identified in the two SAR submodels
provide dues ofalternate mechanisms where-
by ACD may be induced. They need to be
investigated further with respect to their ori-
gin and possible mechanistic significance.
Based on an examination ofthe activity
of chemicals in the NTP rodent carcino-
genicity bioassay and as ACD-inducing
agents, Albert (6) suggested that there was
a component among nongenotoxic car-
cinogens that was shared by human ACD-
inducing agents. He reasoned that the
results of ACD testing and mutagenicity
testing in Salmonella could be complemen-
tary and could be used to identify carcino-
gens. Our results indicate that ACD is dri-
ven, to a large part, by nonelectrophilic
mechanisms. Our findings, however, do
not address the question ofwhether activity
as an ACD-inducing agent can comple-
ment mutagenicity in Salmonella in pre-
dicting potential carcinogens.
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